Commitee for Advanced Therapies
The Committee for Advanced Therapies (CAT) is responsible for providing scientific opinions on all questions relating to advanced-therapy medicinal products, before the Committee for Medicinal Products for Human Use (CHMP) adopts a final opinion. At the request of the European Medicines Agency Executive Director or of the European Commission, an opinion is also drawn up on any scientific matter relating to advanced therapy medicinal products.
The meeting involves the participation of representatives from the National Competent Authorities (NCA’s), including European Economic Area Competent Authorities (Iceland, Norway and Liechtenstein), the European Commission and the European Medicines Agency.
The CAT holds monthly meetings, except for the month of August, at the premises of the European Medicines Agency, based in London. Informal meetings can be organized by the Member State holding the Presidency of the Council of the European Union.
An informal meeting of the CAT will be held on 30 September – 01 October (Antwerp) during the Belgian Presidency. Joint meetings with the Committee for Medicinal Products for Human Use, the Committee for Orphan Medicinal Products, the Paediatric Committee and the Scientific Advice Working Party are foreseen.